Accenture delivered a robust QQ1 2025 performance, underscoring the company’s strategic shift toward large-scale reinventions and AI-enabled transformations. Revenue of $17.69 billion rose 8% in local currency, and was approximately $240 million above the top end of the guided range, driven by broad-based demand across geographic regions and industry verticals. New bookings totaled $18.7 billion, including about $1.2 billion in GenAI bookings and roughly $500 million in GenAI-related revenue, signaling meaningful traction in GenAI-driven engagements. Operating margin stood at 16.7% for the quarter, largely flat against the prior-year adjusted result, reflecting continued investments in talent and platforms as Accenture scales its AI-enabled solutions. Diluted EPS was $3.59, up ~10% year over year on an adjusted basis, and free cash flow was $870 million. The balance sheet remained robust, with cash and cash equivalents of about $8.31 billion and a net cash position of roughly $0.16 billion, enabling acquisitions (five deals totaling ~$242 million) and a strong capital return program (share repurchases of $898 million and a $926 million dividend in the quarter). Management highlighted GenAI as a core growth catalyst and reiterated a capital-return framework supported by a flexible balance sheet. Looking ahead, management maintained a full-year revenue growth target of 4% to 7% in local currency, with around 3% inorganic contribution, and an operating margin target of 15.6% to 15.8%, signaling a deliberate, disciplined growth stance anchored by AI-driven core transformations and cloud-enabled platforms.